Hosted on MSN
Purple Biotech presents new IM1240 preclinical data showing anti-tumor activity and broad therapeutic window (PPBT)
New data presented at EACR 2026 highlighted anti-tumor activity, improved safety characteristics, and pharmacokinetic advantages for Purple Biotech’s lead immunotherapy candidate as it advances toward ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results